BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8402619)

  • 1. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.
    Winqvist R; Mannermaa A; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee W
    Cancer Res; 1993 Oct; 53(19):4486-8. PubMed ID: 8402619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 11q22-q23 in breast cancer.
    Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
    Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
    Tran YK; Newsham IF
    Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
    Nagai H; Negrini M; Carter SL; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
    Cancer Res; 1995 Apr; 55(8):1752-7. PubMed ID: 7712484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.
    Negrini M; Rasio D; Hampton GM; Sabbioni S; Rattan S; Carter SL; Rosenberg AL; Schwartz GF; Shiloh Y; Cavenee WK
    Cancer Res; 1995 Jul; 55(14):3003-7. PubMed ID: 7606718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
    Koreth J; Bakkenist CJ; McGee JO
    Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.
    Baffa R; Negrini M; Mandes B; Rugge M; Ranzani GN; Hirohashi S; Croce CM
    Cancer Res; 1996 Jan; 56(2):268-72. PubMed ID: 8542579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
    Hampton GM; Mannermaa A; Winqvist R; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee WK; Evans GA
    Cancer Res; 1994 Sep; 54(17):4586-9. PubMed ID: 8062246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
    di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M
    Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.
    Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA
    Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for two bladder cancer suppressor loci on human chromosome 9.
    Ruppert JM; Tokino K; Sidransky D
    Cancer Res; 1993 Nov; 53(21):5093-5. PubMed ID: 8221642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.